ArticleProceedings of the National Academy of Sciences of the United States of America2026
Smooth-to-rough morphotype switching, a mechanism of phage resistance in
Abstract read
In one paragraph
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detectable effects of bacterial phylogeny on virulence but not phage efficacy in anISME communications · 2026Article
Corrections and comments
- Commented on by
Authors and funding
25 authors.
Jun Hao Liew *A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.ORCID 0009-0004-2464-9629
Ayuni Norman *A*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.ORCID 0000-0002-9189-0410
Morgane IllouzCentre National de la Recherche Scientifique, UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, Montpellier 34293, France.ORCID 0009-0001-4732-8631
Teck-Hui TeoA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.
Riccardo Delli PontiA*STAR Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore.
Claire HamelaCentre National de la Recherche Scientifique, UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, Montpellier 34293, France.
Lalit MohanA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.ORCID 0000-0002-7657-4639
Renee LewLee Kong Chian School of Medicine, Experimental Medicine Building, Nanyang Technological University, Singapore 636921, Singapore.ORCID 0009-0007-6459-0264
Chanvutha RonA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.
Kay En LowElectron Microscopy Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117549, Singapore.
Wassim DaherCentre National de la Recherche Scientifique, UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, Montpellier 34293, France.ORCID 0000-0001-9026-5333
Aryeh ChiamA*STAR Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore.
Joanna MawLee Kong Chian School of Medicine, Experimental Medicine Building, Nanyang Technological University, Singapore 636921, Singapore.ORCID 0009-0007-0057-189X
Yan SunLee Kong Chian School of Medicine, Experimental Medicine Building, Nanyang Technological University, Singapore 636921, Singapore.
Ria SorayahLee Kong Chian School of Medicine, Experimental Medicine Building, Nanyang Technological University, Singapore 636921, Singapore.ORCID 0000-0001-5594-1658
Stefan H OehlersA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.
Byung Woo JhunDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
Jeanette W P TeoDepartment of Laboratory Medicine, National University Hospital, Singapore 119074, Singapore.
Adeline GouletLaboratoire d'Ingénierie des Systèmes Macromoléculaires, Institut de Microbiologie, Bioénergies et Biotechnologie, CNRS and Aix-Marseille Université, Marseille 13009, France.ORCID 0000-0002-5971-9488
Isabelle BonneInfectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.ORCID 0000-0002-8261-6794
René WintjensUnit of Microbiology, Bioorganic and Macromolecular Chemistry, Department of Research in Drug Development, Faculté de Pharmacie, Université Libre de Bruxelles, Brussels 1050, Belgium.ORCID 0000-0002-0234-7847
Kevin PetheLee Kong Chian School of Medicine, Experimental Medicine Building, Nanyang Technological University, Singapore 636921, Singapore.
Roland G HuberA*STAR Bioinformatics Institute, Agency for Science, Technology and Research, Singapore 138671, Singapore.ORCID 0000-0001-5093-5988
Laurent KremerCentre National de la Recherche Scientifique, UMR 9004, Institut de Recherche en Infectiologie de Montpellier, Université de Montpellier, Montpellier 34293, France.ORCID 0000-0002-6604-4458
Pablo BifaniA*STAR Infectious Diseases Labs, Agency for Science, Technology and Research, 8A Biomedical Grove, Immunos #05-13, Singapore 138648, Singapore.ORCID 0000-0001-9651-6439
Funding
Association Vaincre la Mucoviscidose (French CF Association) RF20200502678 and RF20230503223A*STAR | Biomedical Research Council (BMRC) A*STAR Infectious Diseases Labs core research grantsFondation pour la Recherche Médicale (FRM) Equipe FRM EQU202103012588MOH | National Medical Research Council (NMRC) OFIRG25jan-0127National University Health System (NUHS) NUHSRO/2019/050/T1/Seed-Mar/03PMO | National Research Foundation Singapore (NRF) NRF-CG2025-CG02-IG2-001001PMO | National Research Foundation Singapore (NRF) NRF-CRP26-2021-0006Temasek Foundation (Temasek Foundation International) Temasek Foundation Infectious Diseases Programme for Surveillance and Diseases X Resilience
Abstract
PubMed holds no abstract for this paper.
Indexed as
BacteriophagesMycobacteriophagesMycobacterium abscessusMycobacterium Infections, NontuberculousPhage TherapyHumansMutationmorphotypemycobacteriophageMycobacterium abscessusphage resistancephage therapy
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.